Search

Your search keyword '"Uri Lopatin"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Uri Lopatin" Remove constraint Author: "Uri Lopatin"
28 results on '"Uri Lopatin"'

Search Results

1. Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production.

2. Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection

3. Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection

4. Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

5. Drugs in the Pipeline for HBV

6. Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial

7. US immigration order strikes against biotech

9. Actinomyces in Chronic Granulomatous Disease: An Emerging and Unanticipated Pathogen

10. Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients

11. Transcriptomic analysis of the woodchuck model of chronic hepatitis B

12. Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir

13. Interim safety, tolerability pharmacokinetics, and antiviral activity of ABI-H0731, a novel core protein allosteric modulator, in healthy volunteers and non-cirrhotic viremic subjects with chronic hepatitis B

14. Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression

15. Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season

16. Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes

17. HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels

18. Reduction of HBV replication prolongs the early immunological response to IFNα therapy

19. Lymphotoxin Alpha-Deficient Mice Clear Persistent Rotavirus Infection after Local Generation of Mucosal IgA

20. Targeting Hepatitis B Virus-Infected Cells with a T-Cell Receptor-Like Antibody▿ †

21. Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

22. 1323 THE EFFECT OF HOST IL28B GENOTYPE ON EARLY VIRAL KINETICS DURING INTERFERON-FREE TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C (CHC)

23. 72 TARGETED DELIVERY OF ANTI-VIRAL CYTOKINE TO HBVINFECTED CELLS USING T CELL RECEPTOR-LIKE ANTIBODIES

24. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression

25. Characterization of a Mycobacterium smegmatis mutant that is simultaneously resistant to D-cycloserine and vancomycin

26. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features

27. 1130 SPREADING OF HEPATITIS B VIRUS INFECTION IN UPA MICE IS SENSED BY INNATE ANTIVIRAL DEFENSE MECHANISMS OF HUMAN HEPATOCYTES

28. 1180 A CHROMOSOME 19 SNP (RS12979860) PREDICTS OUTCOME (EVR/SVR) IN HCV PATIENTS TREATED WITH INTERFERON, INDEPENDENT OF PEGYLATION OR RIBAVIRIN

Catalog

Books, media, physical & digital resources